Webinar – Building the early economic case for NHS decision-making

Strong clinical evidence rarely wins funding on its own. NHS decision-makers need to see what your innovation costs, what it saves and what it changes.

That case has to be credible. It also has to arrive early enough to shape your development, rather than late enough to only describe it.

This session shows you how to build an economic case that NHS buyers trust, and how to avoid the mistakes that sink good products.

Who should attend

Early- and mid-stage health technology innovators, SMEs, founders, business development leads, and people leading innovation inside the NHS.

What you’ll learn

• How the NHS judges value. Providers and commissioners want different things. Local and national decisions work differently. NICE sets the tone for both.
• Early economic modelling as a strategic tool. What cost-consequence, early cost-effectiveness and budget impact analysis each tell you, and when to use them.
• Designing evidence the NHS can act on. Which outcomes and economic endpoints influence real adoption decisions.
• Common mistakes. Unrealistic comparators, models built too early, a focus on effectiveness alone, and value articulation left too late.

Find out more and register here